Company Femasys Inc.

Equities

FEMY

US31447E1055

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Ratings for Femasys Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
1.33 ^USD	-3.62%		-4.32%	+36.41%

May. 09	Femasys Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Earnings Flash (FEMY) FEMASYS Reports Q1 Revenue $271,140	MT

Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physicianâs office setting.

Number of employees: 33

USD in Million	2022	Weight	2023	Weight	Delta
FemVue 100.0 %	1	100.0 %	1	100.0 %	-11.13%

USD in Million	2022	Weight	2023	Weight	Delta
United States 94.6 %	1	90.4 %	1	94.6 %	-7.01%
International 5.4 %	0	9.6 %	0	5.4 %	-49.90%

Managers	Title	Age	Since
Kathy Lee-Sepsick FOU	Founder	56	03-12-31
Dov Elefant DFI	Director of Finance/CFO	56	22-02-27
James Liu CTO	Chief Tech/Sci/R&D Officer	-	Nov. 29
Jeremy Sipos CTO	Chief Tech/Sci/R&D Officer	-	11-12-31
Christine Thomas CTO	Chief Tech/Sci/R&D Officer	51	22-10-11
Daniel Currie COO	Chief Operating Officer	60	03-12-31

Members of the board	Title	Age	Since
Charlie Larsen CHM	Chairman	72	15-10-13
Joshua Silverman BRD	Director/Board Member	53	Nov. 20
Kathy Lee-Sepsick FOU	Founder	56	03-12-31
Edward Uzialko BRD	Director/Board Member	73	05-07-31
Alistair Milnes BRD	Director/Board Member	50	23-06-13

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	22,337,941	20,532,203 ( 91.92 %)	117,223 ( 0.5248 %)	91.92 %

Name	Equities	%	Valuation
Edward Uzialko 5.509 %	1,217,406	5.509 %	2 M $
CM Management LLC 1.810 %	400,000	1.810 %	532 000 $
Kathy Lee-Sepsick 1.584 %	350,001	1.584 %	465 501 $
Clear Creek Financial Management LLC 1.399 %	309,274	1.399 %	411 334 $
Vanguard Group, Inc. (Subfiler) 0.8718 %	192,667	0.8718 %	256 247 $
Geode Capital Management LLC 0.8209 %	181,420	0.8209 %	241 289 $
Northern Trust Global Investments Ltd. 0.4064 %	89,801	0.4064 %	119 435 $
Daniel Currie 0.4056 %	89,632	0.4056 %	119 211 $
City National Bank (Los Angeles, California) 0.2395 %	52,935	0.2395 %	70 404 $
STATE STREET CORPORATION 0.1795 %	39,669	0.1795 %	52 760 $

Femasys, Inc.

3950 Johns Creek Court Suite 100

30024, Suwanee

http://www.femasys.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.33 USD

Average target price

10 USD

Spread / Average Target

+651.88%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
FEMASYS INC.	+36.41%	29.39M
ABBOTT LABORATORIES	-4.98%	182B
MEDTRONIC PLC	+2.84%	112B
BECTON, DICKINSON AND COMPANY	-2.68%	68.58B
DEXCOM, INC.	+4.53%	51.58B
CENCORA, INC.	+8.00%	44.24B
HOYA CORPORATION	+9.65%	43.65B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.30%	32.46B
WEST PHARMACEUTICAL SERVICES, INC.	-0.17%	25.61B
TERUMO CORPORATION	+21.57%	25.99B

Other Medical Equipment, Supplies & Distribution